The increasing role of amphiregulin in non-small cell lung cancer

被引：14
作者：
Busser, B. [1 ,2 ]
Coll, J. -L. [1 ]
Hurbin, A. [1 ]
机构：
[1] Univ Grenoble 1, INSERM, U823, Inst Albert Bonniot, F-38042 Grenoble 9, France
[2] CHRU, Hop Michallon, UF Cancerol Biol & Biotherapie, F-38000 Grenoble, France
来源：
PATHOLOGIE BIOLOGIE | 2009年 / 57卷 / 7-8期
关键词：
Amphiregulin; Non-small cell lung cancer; Gefitinib; Growth factor; Apoptosis; Drug resistance; EGFR; Targeted therapy; Tyrosine kinase inhibitors; DEPENDENT PATHWAY; GROWTH; APOPTOSIS;
D O I：
10.1016/j.patbio.2008.10.002
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：511 / 512
页数：2
相关论文
共 50 条
  • [31] The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
    Boland, William
    Bebb, Gwyn
    BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 289 - 298
  • [32] The Emerging Role of Radiotherapy in Oligoprogressive Non-Small Cell Lung Cancer
    Tam, Andrew
    Eustace, Nicholas
    Kassardjian, Ari
    West, Howard
    Williams, Terence M.
    Amini, Arya
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (03) : 497 - 514
  • [33] The role of afatinib in the management of non-small cell lung carcinoma
    Yap, Timothy A.
    Popat, Sanjay
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (11) : 1529 - 1539
  • [34] Approaching the Increasing Complexity of Non-small Cell Lung Cancer Taxonomy
    Maugeri-Sacca, Marcello
    Bartucci, Monica
    Pagliuca, Alfredo
    Patrizii, Michele
    Signore, Michele
    De Maria, Ruggero
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (24) : 3973 - 3981
  • [35] Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
    Takezawa, K.
    Okamoto, I.
    Okamoto, W.
    Takeda, M.
    Sakai, K.
    Tsukioka, S.
    Kuwata, K.
    Yamaguchi, H.
    Nishio, K.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2011, 104 (10) : 1594 - 1601
  • [36] Expression and localization of FOXO1 in non-small cell lung cancer
    Maekawa, Takayo
    Maniwa, Yoshimasa
    Doi, Takefumi
    Nishio, Wataru
    Yoshimura, Masahiro
    Ohbayashi, Chiho
    Hayashi, Yoshitake
    Okita, Yutaka
    ONCOLOGY REPORTS, 2009, 22 (01) : 57 - 64
  • [37] Oligoprogression in Non-Small Cell Lung Cancer
    Harada, Daijiro
    Takigawa, Nagio
    CANCERS, 2021, 13 (22)
  • [38] Non-small cell lung cancer in China
    Chen, Peixin
    Liu, Yunhuan
    Wen, Yaokai
    Zhou, Caicun
    CANCER COMMUNICATIONS, 2022, 42 (10) : 937 - 970
  • [39] Capmatinib for non-small cell lung cancer
    Alzofon, N.
    Jimeno, A.
    DRUGS OF TODAY, 2021, 57 (01) : 17 - 25
  • [40] Gefitinib in non-small cell lung cancer
    Tamura, K
    Fukuoka, M
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 985 - 993
12345